Crystal structure of human mono-phosphorylated ERK1 at Tyr204

被引:50
作者
Kinoshita, Takayoshi [1 ]
Yoshida, Ikuyo [1 ]
Nakae, Setsu [1 ]
Okita, Kouki [2 ]
Gouda, Masaki [2 ]
Matsubara, Marmoru [2 ,3 ]
Yokota, Koichi [2 ]
Ishiguro, Hiroshi [2 ]
Tada, Toshiji [1 ]
机构
[1] Osaka Prefecture Univ, Grad Sch Sci, Naka Ku, Osaka 5998531, Japan
[2] Carna Biosci Inc, Kobe, Hyogo, Japan
[3] Kyoto Gakuen Univ, Fac Bioenvironm Sci, Kyoto, Japan
关键词
MAP kinase; Extracellular signal-regulated protein; kinase; ERK1; Crystal structure;
D O I
10.1016/j.bbrc.2008.10.127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular signal-regulated kinase (ERK) is a member of the MAP kinase family, and can regulate several cellular responses. The isoforms ERK1 and ERK2 have markedly similar amino acid sequences, but exhibit distinctive physiological functions. As well as ERK2, ERK1 was auto- and mono-phosphorylated at Tyr204 in the activation loop during Escherichia coli production, resulting in basal level activity, approximately 500-fold less compared with fully-active ERK1 dual-phosphorylated at Thr202 and Tyr204. Crystal structure demonstrated that the mono-phosphorylated ERK1 kinase possessed a novel conformation distinguishable from the un-phosphorylated (inactive) and the dual-phosphorylated (full-active) forms. The characteristic Structural features in both the C-helix and the activation loop likely contribute to the basal activity of the mono-phosphorylated ERK1. The Structural dissection of ERK1 compared to ERK2 Suggests that the Structural differences in the D-motif binding site and in the backside binding site are putative targets for development of selective ERK1/ERK2 inhibitors. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1123 / 1127
页数:5
相关论文
共 23 条
[1]   Unique MAP kinase binding sites [J].
Akella, Radha ;
Moon, Thomas M. ;
Goldsmith, Elizabeth J. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (01) :48-55
[2]   AN INSULIN-STIMULATED PROTEIN-KINASE SIMILAR TO YEAST KINASES INVOLVED IN CELL-CYCLE CONTROL [J].
BOULTON, TG ;
YANCOPOULOS, GD ;
GREGORY, JS ;
SLAUGHTER, C ;
MOOMAW, C ;
HSU, J ;
COBB, MH .
SCIENCE, 1990, 249 (4964) :64-67
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Activation mechanism of the MAP kinase ERK2 by dual phosphorylation [J].
Canagarajah, BJ ;
Khokhlatchev, A ;
Cobb, MH ;
Goldsmith, EJ .
CELL, 1997, 90 (05) :859-869
[5]   Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure [J].
Chen, Fengming ;
Hancock, Chad N. ;
Macias, Alba T. ;
Joh, Joseph ;
Still, Kimberly ;
Zhong, Shijun ;
MacKerell, Alexander D., Jr. ;
Shapiro, Paul .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (24) :6281-6287
[6]   Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo [J].
Dimitri, CA ;
Dowdle, W ;
MacKeigan, JP ;
Blenis, J ;
Murphy, LO .
CURRENT BIOLOGY, 2005, 15 (14) :1319-1324
[7]   Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases [J].
Johnson, GL ;
Lapadat, R .
SCIENCE, 2002, 298 (5600) :1911-1912
[8]   Crystal structure of human ERK2 complexed with a pyrazolo[3,4-c]pyridazine derivative [J].
Kinoshita, T ;
Warizaya, M ;
Ohori, M ;
Sato, K ;
Neya, M ;
Fujii, T .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) :55-58
[9]   Signal transduction through MAP kinase cascades [J].
Lewis, TS ;
Shapiro, PS ;
Ahn, NG .
ADVANCES IN CANCER RESEARCH, VOL 74, 1998, 74 :49-139
[10]   Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3 [J].
Liu, SJ ;
Sun, JP ;
Zhou, B ;
Zhang, ZY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5326-5331